Viatris (VTRS) Net Margin (2019 - 2026)
Viatris (VTRS) posted Net Margin of 3.16% for Q2 2026, down 163.05% on a QoQ basis from 5.02% in Q1 2026, and down 303.0% year-over-year from 1.56% in Q2 2025.
Powered by 
Analysis
Viatris (VTRS) Net Margin (2019 - 2026) Analysis & Trends
Viatris has reported Net Margin for 8 years, with the latest figure at 3.16% in Q2 2026.
- On a quarterly basis, Net Margin fell 303.0% year-over-year to 3.16% in Q2 2026; TTM through Jun 2026 was 2.79%, a 2178.0% increase from a year earlier, with the FY2025 full-year figure at 24.58%, down 2028.0% from the prior year.
- Net Margin was 3.16% for Q2 2026 at Viatris, down from 5.02% in the prior quarter.
- The five-year high for Net Margin was 26.09% in Q4 2022, with the low at 93.48% in Q1 2025.
- Average Net Margin over 5 years is 3.82%, with a median of 2.82% recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Net Margin slumped 9659 bps in 2025, then jumped 9849 bps in 2026.
- Over 5 years, Net Margin stood at 26.09% in 2022, then sank by 176 bps to 19.95% in 2023, then increased by 27 bps to 14.64% in 2024, then soared by 37 bps to 9.18% in 2025, then jumped by 66 bps to 3.16% in 2026.
- The last three Net Margin figures came in at 3.16% (Q2 2026), 5.02% (Q1 2026), and 9.18% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -13.91% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -3.16% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 5.50% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 8.74% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 9.12% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -121.81% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 9.28% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 16.50% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 11.04% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.16% |
| Mar 31, 2026 | 5.02% |
| Dec 31, 2025 | -9.18% |
| Sep 30, 2025 | -3.41% |
| Jun 30, 2025 | -0.13% |
| Mar 31, 2025 | -93.48% |
| Dec 31, 2024 | -14.64% |
| Sep 30, 2024 | 2.53% |
| Jun 30, 2024 | -8.60% |
| Mar 31, 2024 | 3.11% |
| Dec 31, 2023 | -19.95% |
| Sep 30, 2023 | 8.41% |
| Jun 30, 2023 | 6.74% |
| Mar 31, 2023 | 6.03% |
| Dec 31, 2022 | 26.09% |
| Sep 30, 2022 | 8.69% |
| Jun 30, 2022 | 7.62% |
| Mar 31, 2022 | 9.52% |
| Dec 31, 2021 | -6.08% |
| Sep 30, 2021 | 6.87% |